24 November 2020: Quanta Dialysis Technologies Ltd, a British medical technology company developing innovative dialysis products and services, announces the appointment of John S. Lipman as President of North America. John will lead Quanta’s commercial operations and activities in the United States. He is already working to set up operations and to prepare for commercial […]

31 July, 2020: Quanta Dialysis Technologies Ltd, a British medical technology innovator, today announces that John E. Milad, Chief Executive Officer, will present a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners, on August 4 and 5, 2020. Please click the following link to register: https://lifesci.events/SummerSymposium Presentation Details Date: […]

22 July 2020: Quanta Dialysis Technologies Ltd, a British medical technology innovation company, today announces the appointment of Hooman Hakami to the Company’s Board as an independent Non-Executive Director, with immediate effect. Hooman has 30 years of leadership experience, including senior positions at two of the world’s largest medical devices companies. At Medtronic, he was […]

4 January 2020: Quanta Dialysis Technologies Ltd, a British med-tech company that has developed SC+, a personal haemodialysis (HD) system, today announces that the Company will be presenting at the 40th Annual Dialysis Conference (ADC), which runs from 8 to 11 February 2020, at the Kansas City Convention Center, Missouri, USA. In addition, Quanta announces […]

04 November 2019: Quanta Dialysis Technologies Ltd, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use at home and in the clinic, announces that the Company will be presenting a poster at the ASN conference, reporting on results from an experimental pulsatile push–pull flow mechanism. These results demonstrate feasibility […]

12 August 2019: Quanta Dialysis Technologies Ltd, a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use at home and in the clinic, announces that it has selected Benchmark Electronics Inc. (“Benchmark”) (NYSE:BHE), a global provider of manufacturing, engineering and design services, as its production partner for the SC+ haemodialysis […]

7 August 2019: Quanta Dialysis Technologies Ltd, a British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that it has begun human factors testing of SC+ in the United States with Design Science, a leading specialist in medical device usability. Human factors testing […]

Funds will support UK commercial launch and FDA 510(k) submission later this year 29 July 2019: Quanta Dialysis Technologies Ltd, a British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that it has successfully raised £38 million ($48 million) in a first closing […]

11 July 2019: A major overhaul of American kidney health was announced yesterday by the Trump Administration and the US Department of Health and Human Services. This initiative has enormous potential to improve the lives of American kidney patients by promoting better screening and prevention, making organ transplantation more accessible and providing dialysis patients with […]

11 June 2019: Quanta Dialysis Technologies Ltd, a pioneering British medical device company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announces that the Company will be exhibiting at the 56th Annual European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday […]